Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Vebicorvir plus entecavir safe, effective in chronic HBV patients
Vebicorvir plus entecavir safe, effective in chronic HBV patients
03 Nov 2022 bởiStephen Padilla

The addition of vebicorvir to entecavir in treatment-naïve patients with chronic hepatitis B virus (HBV) infection provides further antiviral activity, with a positive safety and tolerability profile, results of a phase II trial have shown.

Vebicorvir plus entecavir safe, effective in chronic HBV patients
03 Nov 2022
Extended-release nifedipine benefits women with severe pre-eclampsia
Extended-release nifedipine benefits women with severe pre-eclampsia
02 Nov 2022
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
02 Nov 2022 bởiJairia Dela Cruz

Patients with concomitant chronic kidney disease (CKD) and type 2 diabetes (T2D) who are undergoing mineralocorticoid receptor blockade with finerenone are better protected against pneumonia and COVID-19, according to a secondary analysis of data from the FIDELITY trials.

Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
02 Nov 2022
Oral GnRH antagonists effective in endometriosis-related pain, dysmenorrhea
Oral GnRH antagonists effective in endometriosis-related pain, dysmenorrhea
01 Nov 2022
4 anti-obesity meds: AGA top picks
4 anti-obesity meds: AGA top picks
01 Nov 2022 bởiElvira Manzano

Obese adults with weight-related complications who do not respond adequately to lifestyle interventions should be offered one of four anti-obesity medications, according to the new clinical practice guideline on pharmacological interventions released by the American Gastroenterological Association (AGA).

4 anti-obesity meds: AGA top picks
01 Nov 2022